FDA Approved: ZILBRYSQ — Original Application (UCB, Inc.)

View source ↗

Summary

The FDA approved ZILBRYSQ (zilucoplan) via its Original Application from UCB, Inc., for the treatment of generalized myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• ZILBRYSQ (ZILUCOPLAN)

Snippet

ORIG AP for ZILBRYSQ (ZILUCOPLAN)